A randomized multicenter trial to evaluate simple utility elicitation techniques in patients with gastroesophageal reflux disease

Medical Care

Volumn 42, Issue 11, 2004, Pages 1132-1142

  Schünemann, Holger J ^a,b,c,i   Armstrong, David ^c   Degl'innocenti, Alessio ^d   Wiklund, Ingela ^d   Fallone, Carlo A ^e   Tanser, Lisa ^f   Van Zanten, Sander Veldhuyzen ^g   Heels Ansdell, Diane ^c   El Dika, Samer ^a   Chiba, Naoki ^c,h   Barkun, Alan N ^e   Austin, Peggy ^c   Guyatt, Gordon H ^c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d ASTRAZENECA R AND D   (Sweden)

^e MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^f ASTRAZENECA   (United Kingdom)

^g DALHOUSIE UNIVERSITY   (Canada)

^h Surrey GI Clinic   (Canada)

ⁱ MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Clinical trial; Feeling thermometer; Gastroesophageal reflux disease; GERD; Preference measures; Quality of life; Standard gamble; Utilities; Visual analogue scale

Indexed keywords

ESOMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH STATUS; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTICENTER STUDY; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF EVALUATION; STATISTICAL ANALYSIS; VALIDATION PROCESS;

EID: 8144223848     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-200411000-00013     Document Type: Article

References (50)

1. Patrick DL, Erickson P. Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation. Oxford University Press. New York, 1993.
2. Wennberg JE. Outcomes research, cost containment, and the fear of health care rationing. N Engl J Med. 1990;323:1202-1204.
3. Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Tech Ass Health Care. 1989;5:559-575.
4. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622-629.
5. Feeny DH, Torrance GW. Incorporating utility-based quality-of-life assessment measures in clinical trials. Two examples. Med Care. 1989;27(3 Suppl):S190-S204.
6. Mehrez A, Gafni A. Quality-adjusted life years, utility theory, and healthy-years equivalents. Med Decis Making. 1989;9:142-149.
7. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Pol. 1990;16:199-208.
8. Kaplan RM, Bush JW, Berry CC. Health status: types of validity and the Index of Well-being. Health Services Res. 1976;11:478-507.
9. Torrance GW, Furlong W, Feeny D, et al. Multi-attribute preferences functions: Health Utilities Index. Pharmacoeconomics. 1995;6:503-520.
10. Fryback DG, Lawrence WF, Martin PA, et al. Predicting Quality of Well-being scores from the SF-36: results from the Beaver Dam Health Outcomes Study. Med Decis Making. 1997;17:1-9.
11. Brazier J, Usherwood T, Harper R, et al. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol. 1998;51:1115-1128.
12. Nichol MB, Sengupta N, Globe DR. Evaluating quality-adjusted life years: estimation of the health utility index (HUI2) from the SF-36. Med Decis Making. 2001;21:105-112.
13. Bennett KJ, Torrance GW. Measuring health state preferences and utilities: rating scale, time trade-off, and standard gamble techniques. In: Spilker B, ed. Quality Of Life And Pharmacoeconomics In Clinical Trials. 2nd ed. Philadelphia: Lippincott-Raven; 1996:259-260.
14. Brazier J, Deverill M, Green C. The use of health status measures in economic evaluation. In Stevens A, Abrams K, Brazier J, et al, eds. The Advanced Handbook of Methods in Evidence Based Healthcare. London: Sage Publications; 2000:195-214.
15. Neumann PJ, Goldie SJ, Weinstein MC. Preference-based measures in economic evaluation in health care. Annu Rev Public Health. 2000;21:587-611.
16. Green C, Brazier J, Deverill M. Valuing health related quality of life. A review of health state valuation techniques. Pharmacoeconomics. 2000;17:151-165.
17. Llewellyn-Thomas H. Health state descriptions: purposes, issues, a proposal. Med Care. 1996;34:DS109-DS118.
18. Schünemann HJ, Griffith L, Stubbing D, et al. A clinical trial to evaluate the responsiveness and validity of two direct health state preference instruments administered with and without hypothetical marker states in chronic respiratory disease. Med Dec Making. 2003;23:140-149.
19. Llewellyn-Thomas HA, Thiel EC, McGreal MJ. Cancer patients' evaluations of their current health states: the influences of expectations, comparisons, actual health status, and mood. Med Dec Making. 1992;12:115-122.
20. Juniper EF, Thompson AK, Roberts JN. Can the standard gamble and rating scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF-36. Allergy. 2002;57:201-206.
21. Fries JF, Ramey DR. "Arthritis specific" global health analog scales assess "generic" health related quality-of-life in patients with rheumatoid arthritis. J Rheumatol. 1997;24:1697-1702.
22. Bakker C, Rutten M, Vansantenhoeufft M, et al. Patient utilities in fibromyalgia and the association with other outcome measures. J Rheumatol. 1995;22:1536-1543.
23. Juniper EF, Guyatt GH, Feeny DH, et al. Minimum skills required by children to complete health-related quality of life instruments for asthma: comparison of measurement properties. Eur Respir J. 1996;10:2285-2294.
24. Bennett KJ, Torrance GW, Moran LA, et al. Health state utilities in knee replacement surgery: the development and evaluation of McKnee. J Rheumatol. 1997;24:1796-1805.
25. Bennett K, Torrance G, Tugwell P. Methodologic challenges in the development of utility measures of health-related quality of life in rheumatoid arthritis. Contr Clin Trials. 1991;12:118S-128S.
26. Froberg DG, Kane RL. Methodology for measuring health-state preferences-III: population and context effects. J Clin Epidemiol. 1989;42:585-592.
27. Mohide EA, Torrance GW, Streiner DL, et al. Measuring the wellbeing of family caregivers using the time trade-off technique. J Clin Epidemiol. 1988;41:475-482.
28. Mant JWP, Jenkinson C, Murphy MF, et al. Use of the Short Form 36 to detect the influence of upper gastrointestinal disease on self-reported health status. Qual Life Res. 1998;7:221-226.
29. Castell D, Kahrilas P, Richter J, et al. Esomeprazole 40 mg compared with lansoprazole 30 mg in the treatment of erosive esophagitis. Am J Gastroenterol. 2002;97:575-583.
30. Wiklund I. Quality of life in patients with gastroesophageal reflux disease. Am J Gastroenterol. 2001;96(8 Suppl):S46-S53.
31. Richter JE, Kahrilas JP, Johanson J, et al. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Am J Gastroenterol. 2001; 96:656-665.
32. Kahrilas P, Falk GW, Johnson DA, et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. Aliment Pharmacol Ther. 2000;14:1249-1258.
33. Wiklund IK, Junghard O, Grace E, et al. Quality of Life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg. 1998;(Suppl 583):41-40.
34. Schünemann HJ, Stahl E, Austin P, et al. A comparison of presenting hypothetical health states in narrative and point-by-point format: results from two randomized trials. Med Dec Making. 2004;24:53-60.
35. Furlong W, Feeny D, Torrance GW, et al. Guide to design and development of health state utility instrumentation. Centre for Health Economics and Policy Analysis Working Paper Series Number 90-9 (141 pp), McMaster University 1990.
36. Talley NJ, Fullerton S, Junghard O, et al. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol. 2001;96:1998-2004.
37. Ware JE, Snow KK, Kosinski MA. SF-36 Health Survey Manual and Interpretation Guide. Boston: New England Medical Centre; 1993.
38. Gotzsche PC. Blinding during data analysis and writing of manuscripts. Contr Clin Trials. 1996;17:285-290.
39. Schünemann HJ, Griffith L, Jaeschke R, et al. Evaluation of the minimal important difference for the feeling thermometer and St. Georges Respiratory questionnaire in patients with chronic airflow limitation. J Clin Epidemiol. 2003;56:1170-1176.
40. Guyatt GH. Making sense of quality-of-life data. Med Care. 2000; 38(Supp):175-179.
41. Feeny D, Juniper EF, Ferrie PJ, et al. Why not just ask the kids? Health-related quality of life in children with asthma. In: Dennis Drotar ed, Measuring Health-Related Quality of Life in Children and Adolescents: Implications for Research, Practice, and Policy. Mahwah, NJ: Lawrence Erlbaum Associates Publishers; 1998:171-185.
42. Read JL, Quinn RJ, Berwick DM, et al. Preferences for health outcomes: comparisons of assessment methods. Med Decis Making. 1984;4:315-329.
43. Rutten-van Mölken MPMH, Bakker CH, Vandoorslaer EKA, et al. Methodological issues of patient utility measurement - experience from 2 clinical-trials. Med Care. 1995;33:922-937.
44. Torrance GW. Social preferences for health states: an empirical evaluation of three measurement techniques. Socioecon Planning Sci. 1976; 10:129-136.
45. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to their Development and Use. 2nd ed. Oxford: Oxford University Press; 1995.
46. Robinson A, Loomes G, Jones-Lee M. Visual analog scales, standard gambles, and relative risk aversion. Med Decis Making. 2001;21:17-27.
47. Bleichrodt H, Johannesson M. An experimental test of a theoretical foundation for rating-scale valuations. Med Decis Making. 1997;17: 208-216.
48. Guyatt GH, Berman LB, Townsend M, et al. Should study subjects see their previous responses? J Chron Dis. 1985;38:1003-1007.
49. Guyatt GH, Townsend M, Keller JL, et al. Should study subjects see their previous responses: data from a randomized control trial. J Clin Epidemiol. 42:913-920.
50. Schunemann HJ, Guyatt GH, Griffith L, et al. A randomized controlled trial to evaluate the effect of informing patients about their pretreatment responses to two respiratory questionnaires. Chest. 2002;122:1701-1708.